Adverse Pregnancy Outcomes Linked to Increased Risk for Peripheral Artery Disease MONDAY, July 27, 2026 -- Adverse pregnancy outcomes are associated with an increased risk for peripheral artery disease (PAD) up to 46 years later, according to a study published
The GLP-1 research reinforces the value of this comprehensive model and opens new possibilities for the role that medication-assisted approaches can play in individualized treatment plans
Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2
Tirzepatide takes it a step further by activating both GLP-1 and GIP receptors, making it even more effective in reducing hunger and improving insulin response, which can lead to greater weight loss results
Growth hormone is a peptide hormone produced by somatotroph cells in the anterior pituitary gland
Avoid direct sun exposure during peak hours (11 AM to 4 PM)